Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Vaccination in Pregnancy: Patient Attitudes

Vaccine; ePub 2018 Jun 12; Strassberg, et al

Providers can improve tetanus-diphtheria-acellular pertussis (Tdap) and influenza vaccination acceptance in pregnancy by recommending the vaccination in combination with provision of educational materials on the vaccines, a recent study found. From December 2014 to April 2015, women were given a questionnaire eliciting their experiences, attitudes, and history of influenza and Tdap vaccination in pregnancy during their routine prenatal care appointments at a tertiary care center. Patient demographics were included in the questionnaire. A similar questionnaire was administered to prenatal care providers. Researchers found:

  • Out of the 400 patient questionnaires distributed, 338 (84.5%) were completed and returned; 24 of 45 (53.3%) provider questionnaires were returned.
  • Vaccination acceptance rates were 70.7% for the influenza vaccine and 76.3% for the Tdap vaccine.
  • Patient attitudes were more favorable towards Tdap than influenza vaccination.
  • The combination of healthcare provider recommendation and educational materials was significantly predictive of both Tdap and influenza vaccine acceptance.
  • The most common reasons given for declining the influenza vaccine were safety concerns; the most common reasons given for declining the Tdap vaccine were that patients did not think it was required again when they received the vaccine before pregnancy.
Citation:

Strassberg ER, Power M. Schulkin J, et al. Patient attitudes toward influenza and tetanus, diphtheria and acellular pertussis vaccination in pregnancy. [Published online ahead of print June 12, 2018]. Vaccine. doi:10.1016/j.vaccine.2018.05.121.